Clinical Trial Patient Recruitment Services Market
Clinical Trial Patient Recruitment Services Market Forecasts to 2030 - Global Analysis By Therapeutic Areas (Central Nervous System, Anti-Infective, Endocrine, Respiratory Diseases, Cardiovascular, Pain & Anesthesia, Oncology, Dermatological Disorders , Hematological Disorders and Other Therapeutic Areas), Phase (Phase I, Phase II, Phase Ill and Phase IV), Age Group and By Geography
Years Covered |
2021-2030 |
Estimated Year Value (2023) |
US $1.19 BN |
Projected Year Value (2030) |
US $2.55 BN |
CAGR (2023 - 2030) |
11.5% |
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
Largest Market |
North America |
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Clinical Trial Patient Recruitment Services Market is accounted for $1.19 billion in 2023 and is expected to reach $2.55 billion by 2030 growing at a CAGR of 11.5% during the forecast period. Services specifically designed to assist researchers and pharmaceutical companies in finding and recruiting qualified subjects for their clinical trials are known as clinical trial patient recruitment services. In order to help clinical trials get underway more quickly, patient recruitment services can speed up the process of identifying and enrolling eligible participants. For researchers to better understand a treatment's efficacy and safety across a range of demographic groups it is imperative to have a more diverse and representative patient population, which is a factor that patient recruitment services can help ensure.
According to ClinicalTrial.gov, there has been a 49.2% rise in clinical trials over the past 5 years.
Market Dynamics:
Driver:
Rising Number of Clinical Trials
One major factor propelling the market for clinical trial patient recruitment services is the rise in the number of clinical trials. The ongoing developments in pharmaceutical research, medical research, and the search for novel therapies and treatments are the main drivers of this rise in clinical trial activity. Specialized patient recruitment services are in increasing demand as pharmaceutical and biotechnology companies, academic institutions, and research organizations step up their efforts to introduce novel drugs, medical devices, and therapies to the market.
Restraint:
Budgetary restrictions
Budgetary restrictions are a typical problem for research institutions and pharmaceutical companies. Although patient recruitment services are essential to the smooth running of trials, their costs can be a significant factor. These services usually come with a number of costs, such as hiring staff, using cutting-edge technologies, advertising, and outreach programs to find and connect possible trial participants. Furthermore, providers of patient recruitment services may feel pressured to offer competitive pricing in a market that is fiercely competitive, which could affect their profit margins and capacity to make investments in cutting-edge tactics and technologies. Therefore, it is a significant barrier to market growth.
Opportunity:
Advanced technologies
Numerous recruitment agencies use advanced technologies, like artificial intelligence and data analytics, to improve participant identification accuracy and efficiency. Data analytics is being used by patient recruitment services in increasing numbers to quickly and accurately identify possible trial participants by sorting through large datasets. This analytical method makes it possible to identify people who fit the precise requirements of each clinical trial by methodically evaluating a variety of patient characteristics and medical histories. These factors propel market demand.
Threat:
Regulatory challenges
The regulatory landscape for clinical trials is complex and subject to constant change. Recruitment agencies may find it difficult to remain compliant with changing regulations, such as those pertaining to data protection and informed consent. Additionally, there are stringent regulations pertaining to patient privacy, data protection, and informed consent that apply to clinical trials. Patient recruitment services may find it difficult to comply with regulatory bodies' strict guidelines when it comes to gathering, storing, and sharing patient data. These factors hamper market expansion.
Covid-19 Impact
The COVID-19 pandemic has had a significant impact on the clinical trial patient recruitment services market. Numerous ongoing clinical trials were disrupted by the pandemic, which had a significant negative impact on trial enrolment and patient recruitment. Phase-outs, travel bans, and restricted access to medical facilities made it difficult to carry out trials as scheduled. In order to improve remote monitoring capabilities and collect real-time patient data while minimizing the need for in-person visits, patient recruitment services worked with tech companies.
The respiratory diseases segment is expected to be the largest during the forecast period
The respiratory diseases segment is estimated to hold the largest share. The Clinical Trial Patient Recruitment Services' respiratory diseases section focuses on a particular field of clinical research that is committed to the creation of cures and treatments for a range of respiratory ailments. For the purpose of assessing the safety and effectiveness of novel medications, inhalers, biologics, and medical devices intended to enhance lung function, reduce symptoms, or stop exacerbations, clinical trials are crucial.
The phase II segment is expected to have the highest CAGR during the forecast period
The phase II segment is anticipated to have lucrative growth during the forecast period. In the clinical research spectrum, Phase II clinical trials are a crucial stage that comes after Phase I trials and before Phase III trials. The main goals of Phase II trials are to evaluate a new treatment or medication's safety and effectiveness in a larger patient population. The Phase II segment recruitment services are responsible for identifying and enrolling eligible participants who meet the precise requirements specified in the trial protocol.
Region with largest share:
North America commanded the largest market share during the extrapolated period due to the large number of active clinical trials in the region, the market is anticipated to increase rapidly. Significant R&D expenditures and government funding for clinical studies also drive the industry. The industry's growth in North America has been facilitated by the existence of top contract research organizations (CROs) that provide extensive support services, such as patient recruiting, and by the active involvement of global pharmaceutical and biopharmaceutical corporations.
Region with highest CAGR:
Asia Pacific is expected to witness profitable growth over the projection period. There is an increase in off shoring clinical trials to emerging economies like India, Japan, South Korea, and others. This is because there is a large patient pool and trials are inexpensive, which further promotes regional expansion. The availability of qualified medical professionals, a robust hospital network, and developed clinical research infrastructure are all contributing to the Asia-Pacific market's expansion.
Key players in the market
Some of the key players in the Clinical Trial Patient Recruitment Services Market include Clinical Site Services, Clara Health, Worldwide Clinical Trials, Clariness, Veristat, PPD Inc, BBK Worldwide, Elligo Health Research, Antidote Technologies, Inc., IQVIA, Matthews Media Group Inc., Conduent, Inc., Biorasi, LLC, Trialfacts and Syneos Health.
Key Developments:
In August 2023, Worldwide Clinical partners with Cybin for psychedelic-based treatments. Cybin, a biopharma developing psychedelic-based treatment options for mental health issues.
In December 2021, worldwide clinical Trials and WCG partner to accelerate and streamline global safety event distribution. Worldwide offers a comprehensive suite of pharmacovigilance capabilities, including a regulatory intelligence database that is unique to the company and enhanced by WCG’s proprietary Safety Vigilance portal.
Therapeutic Areas Covered:
• Central Nervous System
• Anti-Infective
• Endocrine
• Respiratory Diseases
• Cardiovascular
• Pain & Anaesthesia
• Oncology
• Dermatological Disorders
• Haematological Disorders
• Other Therapeutic Areas
Phases Covered:
• Phase I
• Phase II
• Phase Ill
• Phase IV
Age Groups Covered:
• Child
• Adult
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Clinical Trial Patient Recruitment Services Market, By Therapeutic Areas
5.1 Introduction
5.2 Central Nervous System
5.3 Anti-Infective
5.4 Endocrine
5.5 Respiratory Diseases
5.6 Cardiovascular
5.7 Pain & Anesthesia
5.8 Oncology
5.9 Dermatological Disorders
5.10 Hematological Disorders
5.11 Other Therapeutic Areas
6 Global Clinical Trial Patient Recruitment Services Market, By Phase
6.1 Introduction
6.2 Phase I
6.3 Phase II
6.4 Phase Ill
6.5 Phase IV
7 Global Clinical Trial Patient Recruitment Services Market, By Age Group
7.1 Introduction
7.2 Child
7.3 Adult
8 Global Clinical Trial Patient Recruitment Services Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Clinical Site Services
10.2 Clara Health
10.3 Worldwide Clinical Trials
10.4 Clariness
10.5 Veristat
10.6 PPD Inc
10.7 BBK Worldwide
10.8 Elligo Health Research
10.9 Antidote Technologies, Inc.
10.10 IQVIA
10.11 Matthews Media Group Inc.
10.12 Conduent, Inc.
10.13 Biorasi, LLC
10.14 Trialfacts
10.15 Syneos Health
List of Tables
1 Global Clinical Trial Patient Recruitment Services Market Outlook, By Region (2021-2030) ($MN)
2 Global Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
3 Global Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
4 Global Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
5 Global Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
6 Global Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
7 Global Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
8 Global Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
9 Global Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
10 Global Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
11 Global Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
12 Global Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
13 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
14 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
15 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
16 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
17 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
18 Global Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
19 Global Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
20 Global Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
21 North America Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
22 North America Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
23 North America Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
24 North America Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
25 North America Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
26 North America Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
27 North America Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
28 North America Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
29 North America Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
30 North America Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
31 North America Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
32 North America Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
33 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
34 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
35 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
36 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
37 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
38 North America Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
39 North America Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
40 North America Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
41 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
42 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
43 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
44 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
45 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
46 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
47 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
48 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
49 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
50 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
51 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
52 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
53 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
54 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
55 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
56 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
57 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
58 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
59 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
60 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
61 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
62 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
63 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
64 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
65 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
66 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
67 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
68 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
69 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
70 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
71 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
72 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
73 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
74 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
75 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
76 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
77 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
78 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
79 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
80 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
81 South America Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
82 South America Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
83 South America Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
84 South America Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
85 South America Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
86 South America Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
87 South America Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
88 South America Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
89 South America Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
90 South America Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
91 South America Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
92 South America Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
93 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
94 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
95 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
96 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
97 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
98 South America Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
99 South America Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
100 South America Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
101 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
102 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
103 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN) 104 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
105 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
106 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
107 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
108 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
109 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
110 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN) 111 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN) 112 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN) 113 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
114 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
115 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
116 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
117 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
118 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
119 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
120 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.